Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yiming Cheng

Showing results (41-50 of 69) with videos related to

Pageof 7
Sort By:
The EMBO Journal|August 26, 2020
CARD8 inflammasome activation triggers pyroptosis in human T cellsAndreas Linder, Stefan Bauernfried, Yiming Cheng, et al.
ACS Applied Materials & Interfaces|August 2, 2022
Enhancement of Thermoelectric Performance in Bi<sub>0.5</sub>Sb<sub>1.5</sub>Te<sub>3</sub> Particulate Composites Including Ferroelectric BaTiO<sub>3</sub> NanodotsYiming Cheng, Junyou Yang, Yubo Luo, et al.
British Journal of Clinical Pharmacology|August 18, 2022
Model-based analysis for the population pharmacokinetics of iberdomide and its major active metabolite in healthy subjects and patients with relapsed and refractory multiple myelomaYiming Cheng, Yongjun Xue, Lu Chen, et al.
Clinical Pharmacology : Advances and Applications|March 7, 2023
A Phase 1, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics of Iberdomide in Subjects with Mild, Moderate, or Severe Hepatic Impairment Compared with Healthy SubjectsYiming Cheng, Ying Ye, Allison Gaudy, et al.
The AAPS Journal|April 29, 2025
Model-informed Drug Development (MIDD) Approach to Support Biopharmaceutical Development of IberdomideCaroline Sychterz, Ping Chen, Ajay Saxena, et al.
Clinical Pharmacology in Drug Development|April 20, 2023
Exposure-Response Analysis to Assess the Concentration-QTc Relationship of IberdomideYiming Cheng, Allison Gaudy, Liangang Liu, et al.
Cell|November 29, 2019
TLR8 Is a Sensor of RNase T2 Degradation ProductsWilhelm Greulich, Mirko Wagner, Moritz M Gaidt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 21, 2025
Population Pharmacokinetics of Orvacabtagene Autoleucel, an Autologous BCMA-Directed Chimeric Antigen Receptor T-cell Product, in Patients with Relapsed/Refractory Multiple MyelomaHongxiang Hu, Yan Li, Julia Piasecki, et al.
Endocrine|November 8, 2023
The value of Korean, American, and Chinese ultrasound risk stratification systems combined with BRAF(V600E) mutation for detecting papillary thyroid carcinoma in cytologically indeterminate thyroid nodulesYu Lin, Yiming Cheng, Yan Zhang, et al.
ACS Applied Materials & Interfaces|February 8, 2022
High Thermoelectric Performance SnTe with a Segregated and Percolated StructureZheng Ma, Tian Xu, Wang Li, et al.
Pageof 7

Showing results (41-50 of 69) with videos related to

Sort By:
Pageof 7
The EMBO Journal|August 26, 2020
CARD8 inflammasome activation triggers pyroptosis in human T cellsAndreas Linder, Stefan Bauernfried, Yiming Cheng, et al.
ACS Applied Materials & Interfaces|August 2, 2022
Enhancement of Thermoelectric Performance in Bi<sub>0.5</sub>Sb<sub>1.5</sub>Te<sub>3</sub> Particulate Composites Including Ferroelectric BaTiO<sub>3</sub> NanodotsYiming Cheng, Junyou Yang, Yubo Luo, et al.
British Journal of Clinical Pharmacology|August 18, 2022
Model-based analysis for the population pharmacokinetics of iberdomide and its major active metabolite in healthy subjects and patients with relapsed and refractory multiple myelomaYiming Cheng, Yongjun Xue, Lu Chen, et al.
Clinical Pharmacology : Advances and Applications|March 7, 2023
A Phase 1, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics of Iberdomide in Subjects with Mild, Moderate, or Severe Hepatic Impairment Compared with Healthy SubjectsYiming Cheng, Ying Ye, Allison Gaudy, et al.
The AAPS Journal|April 29, 2025
Model-informed Drug Development (MIDD) Approach to Support Biopharmaceutical Development of IberdomideCaroline Sychterz, Ping Chen, Ajay Saxena, et al.
Clinical Pharmacology in Drug Development|April 20, 2023
Exposure-Response Analysis to Assess the Concentration-QTc Relationship of IberdomideYiming Cheng, Allison Gaudy, Liangang Liu, et al.
Cell|November 29, 2019
TLR8 Is a Sensor of RNase T2 Degradation ProductsWilhelm Greulich, Mirko Wagner, Moritz M Gaidt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 21, 2025
Population Pharmacokinetics of Orvacabtagene Autoleucel, an Autologous BCMA-Directed Chimeric Antigen Receptor T-cell Product, in Patients with Relapsed/Refractory Multiple MyelomaHongxiang Hu, Yan Li, Julia Piasecki, et al.
Endocrine|November 8, 2023
The value of Korean, American, and Chinese ultrasound risk stratification systems combined with BRAF(V600E) mutation for detecting papillary thyroid carcinoma in cytologically indeterminate thyroid nodulesYu Lin, Yiming Cheng, Yan Zhang, et al.
ACS Applied Materials & Interfaces|February 8, 2022
High Thermoelectric Performance SnTe with a Segregated and Percolated StructureZheng Ma, Tian Xu, Wang Li, et al.
Pageof 7